PacaÑa, Aniebe M.
HRN: 23-13-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2023
CEFTRIAXONE 1G (VIAL)
06/10/2023
06/16/2023
IV
2gm
Q24H
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes